Ultrahypofractionated partial breast irradiation following oncoplastic surgery: secondary analysis of a phase II trial.

IF 3.3 2区 医学 Q2 ONCOLOGY
Rachel Radigan, Sophia L Fu, Austin Barney, Jeffrey Pettit, Vani Gupta, Shridevi Singh, Marlene Mancuso, Vikram Soni, Jana Deitch, Andrew T Wong, Johnny Kao
{"title":"Ultrahypofractionated partial breast irradiation following oncoplastic surgery: secondary analysis of a phase II trial.","authors":"Rachel Radigan, Sophia L Fu, Austin Barney, Jeffrey Pettit, Vani Gupta, Shridevi Singh, Marlene Mancuso, Vikram Soni, Jana Deitch, Andrew T Wong, Johnny Kao","doi":"10.1186/s13014-025-02630-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Although partial breast irradiation (PBI) is accepted as an effective and cosmesis-preserving technique for low-risk early-stage breast cancer following standard lumpectomy, data supporting PBI following oncoplastic surgery are sparse. We report prospective data in efforts to determine whether PBI can be safely utilized after oncoplastic surgery.</p><p><strong>Methods: </strong>Patients with low-risk stage 0-1 breast cancer following successful lumpectomy with optional oncoplastic reconstruction were enrolled on a phase II trial. Patients were treated with a modified Florence regimen to 30 Gy in 5 fractions on the Varian Edge radiosurgery system using IMRT or VMAT. Presurgical MRI, post-operative seroma and surgical clips were used to assist target delineation. The effect of oncoplastic surgery on radiation dosimetry and Breast Cancer Treatment Outcome Scale scores were assessed using student's t-test for continuous variables and chi-square for categorical variables.</p><p><strong>Results: </strong>From 2018 to 2022, 50 patients with 52 tumors were enrolled with 48% undergoing oncoplastic reconstruction. Although median PTV volumes were numerically larger in the oncoplastic group (266 cc vs. 223 cc), there were no statistically significant differences in PTV volumes, ratio of PTV to whole breast or mean heart or lung doses (p > 0.05). Mean baseline BCTOS aesthetic scores were 1.35 for standard lumpectomy vs. 2.52 for oncoplastic (p = 0.003). At long-term follow-up > 2 years, mean BCTOS aesthetic scores were 1.29 for standard lumpectomy vs. 1.35 for oncoplastic (p = 0.71). At a median follow-up of 46 months, there were no local recurrences.</p><p><strong>Conclusions: </strong>When utilizing pre-treatment MRI, surgical clips and a relatively large PTV, PBI after oncoplastic surgery was safe and effective for appropriately selected patients. In combination with oncoplastic surgery, partial breast irradiation achieves excellent long-term cosmesis that improves over time.</p>","PeriodicalId":49639,"journal":{"name":"Radiation Oncology","volume":"20 1","pages":"53"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11998419/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13014-025-02630-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Although partial breast irradiation (PBI) is accepted as an effective and cosmesis-preserving technique for low-risk early-stage breast cancer following standard lumpectomy, data supporting PBI following oncoplastic surgery are sparse. We report prospective data in efforts to determine whether PBI can be safely utilized after oncoplastic surgery.

Methods: Patients with low-risk stage 0-1 breast cancer following successful lumpectomy with optional oncoplastic reconstruction were enrolled on a phase II trial. Patients were treated with a modified Florence regimen to 30 Gy in 5 fractions on the Varian Edge radiosurgery system using IMRT or VMAT. Presurgical MRI, post-operative seroma and surgical clips were used to assist target delineation. The effect of oncoplastic surgery on radiation dosimetry and Breast Cancer Treatment Outcome Scale scores were assessed using student's t-test for continuous variables and chi-square for categorical variables.

Results: From 2018 to 2022, 50 patients with 52 tumors were enrolled with 48% undergoing oncoplastic reconstruction. Although median PTV volumes were numerically larger in the oncoplastic group (266 cc vs. 223 cc), there were no statistically significant differences in PTV volumes, ratio of PTV to whole breast or mean heart or lung doses (p > 0.05). Mean baseline BCTOS aesthetic scores were 1.35 for standard lumpectomy vs. 2.52 for oncoplastic (p = 0.003). At long-term follow-up > 2 years, mean BCTOS aesthetic scores were 1.29 for standard lumpectomy vs. 1.35 for oncoplastic (p = 0.71). At a median follow-up of 46 months, there were no local recurrences.

Conclusions: When utilizing pre-treatment MRI, surgical clips and a relatively large PTV, PBI after oncoplastic surgery was safe and effective for appropriately selected patients. In combination with oncoplastic surgery, partial breast irradiation achieves excellent long-term cosmesis that improves over time.

肿瘤整形手术后的超低分割部分乳房照射:II期试验的二次分析。
目的:虽然部分乳房照射(PBI)被认为是标准乳房肿瘤切除术后低风险早期乳腺癌的一种有效和保留乳房的技术,但支持肿瘤整形手术后PBI的数据很少。我们报告了前瞻性数据,以确定PBI是否可以在肿瘤整形手术后安全使用。方法:低风险0-1期乳腺癌患者在成功的乳房肿瘤切除术后可选择肿瘤整形重建,纳入II期试验。患者在Varian Edge放射外科系统上使用IMRT或VMAT进行改良的Florence方案治疗,治疗剂量为30 Gy,分为5个部分。术前MRI、术后血肿及手术夹辅助靶区划定。肿瘤整形手术对放射剂量学和乳腺癌治疗结局量表评分的影响采用连续变量的学生t检验和分类变量的卡方检验进行评估。结果:2018年至2022年,共纳入50例患者,共52例肿瘤,其中48%接受肿瘤整形重建。虽然肿瘤组中位PTV体积在数值上更大(266 cc vs 223 cc),但PTV体积、PTV与全乳房的比值或平均心脏或肺部剂量的差异无统计学意义(p < 0.05)。标准乳房肿瘤切除术的平均基线BCTOS美学评分为1.35,而肿瘤切除术的平均基线BCTOS美学评分为2.52 (p = 0.003)。长期随访2年,标准乳房肿瘤切除术的平均BCTOS美学评分为1.29,而肿瘤切除术的平均BCTOS美学评分为1.35 (p = 0.71)。中位随访46个月,无局部复发。结论:通过术前MRI、手术夹和较大的PTV,对适当选择的患者进行肿瘤整形术后PBI是安全有效的。与肿瘤整形手术相结合,部分乳房照射可以实现长期的良好美容,并随着时间的推移而改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiation Oncology
Radiation Oncology ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
6.50
自引率
2.80%
发文量
181
审稿时长
3-6 weeks
期刊介绍: Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信